Cowen and Company’s HUMANIGEN, INC. HGEN Stock Holding History

Cowen and Company’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,200	Closed	-$29K	–	756
2021 Q1	$29K	Buy	+15,200	New	+$277K	﹤0.01%	433

Other funds holding HGEN

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cowen and Company's HGEN Position: Q3 2022 in Review

Cowen and Company sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 1,128,174 shares — an estimated $2M sold.

Cowen and Company first reported a position in HGEN in Q1 2021 and held it in 3 quarters. The position peaked at $2.26M in Q1 2022. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

Cowen and Company reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
Cowen and Company sold 1,128,174 HUMANIGEN, INC. shares in Q3 2022, an estimated $2M.
Cowen and Company first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 3 quarters.
Cowen and Company's HUMANIGEN, INC. position peaked at $2.26M in Q1 2022.
53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.